January 1, 2000Journal of Cardiovascular Pharmacology
Sympathetic Nervous System Activation in Essential Hypertension, Cardiac Failure and Psychosomatic Heart Disease
Key result
Sympathetic nervous system activation contributes to the pathophysiology of essential hypertension, heart failure, and psychosomatic heart disease, with distinct regional patterns in obesity.
Population
Patients with essential hypertension, obesity-related hypertension, heart failure, and psychosomatic heart…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May guide sympathetic-targeted therapies in hypertension and HF; leaves open optimal regional interventions in obesity.
Structured PICO
P
Population
Patients with essential hypertension, obesity-related hypertension, heart failure, and psychosomatic heart disease
This review highlights the central role of sympathetic nervous system activation in the pathophysiology of various cardiovascular conditions, including hypertension and heart failure.
Cite This Study
Esler et al. (2000) conducted a review in Essential hypertension, cardiac failure, and psychosomatic heart disease. Sympathetic nervous system activation was evaluated. Sympathetic nervous system activation contributes to the pathophysiology of essential hypertension, heart failure, and psychosomatic heart disease, with distinct regional patterns in obesity.